
---
title: '确定了调节前列腺癌缺氧的分子机制'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202209/06/212917vsd3dtokct6d3oyk.jpg'
author: 科学网
comments: false
date: Tue, 06 Sep 2022 21:38:00 GMT
thumbnail: 'https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202209/06/212917vsd3dtokct6d3oyk.jpg'
---

<div>   
<p style="line-height: 3em;"><span style="font-family: "times new roman"; font-size: 24px;">确定了调节前列腺癌缺氧的分子机制</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">诸平</span></p><p style="text-align: center;"><img src="https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202209/06/212917vsd3dtokct6d3oyk.jpg" title alt="prostatecanc.jpg" referrerpolicy="no-referrer"><br></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">Fig. 1 Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia, </span><a href="https://creativecommons.org/licenses/by-sa/3.0/deed.en" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">CC BY-SA 3.0</span></a></p><p style="text-align: center;"><a href="https://news.feinberg.northwestern.edu/2022/09/02/molecular-mechanisms-regulating-prostate-cancer-hypoxia-identified/" target="_self"><img src="https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202209/06/213016m3x53kxzxy3o7gox.jpg" title alt="YU_Jindan_MD_PhD_20170905_MPP0472-255x300.jpg" width="310" height="351" style="width: 310px; height: 351px;" referrerpolicy="no-referrer"></a><br></p><p style="line-height: 2em;"><a href="https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=18755" style="font-size: 18px; font-family: "times new roman"; text-decoration: underline;" target="_blank"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-family: "times new roman"; font-size: 18px;">Fig. 2 </span>Jindan Yu, MD, PhD</span></a><span style="font-size: 18px; font-family: "times new roman";">, professor of </span><a href="https://www.medicine.northwestern.edu/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Medicine</span></a><span style="font-size: 18px; font-family: "times new roman";"> in the Division of </span><a href="https://www.medicine.northwestern.edu/divisions/hematology-oncology/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Hematology and Oncology</span></a><span style="font-size: 18px; font-family: "times new roman";"> and of </span><a href="http://www.feinberg.northwestern.edu/sites/biochem/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Biochemistry and Molecular Genetics</span></a><span style="font-size: 18px; font-family: "times new roman";">, <a href="https://news.feinberg.northwestern.edu/2022/09/02/molecular-mechanisms-regulating-prostate-cancer-hypoxia-identified/" target="_self">was senior author of the study published in Oncogene</a>.</span></p><p style="text-align: center;"><img src="https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202209/06/213059ihh16195kz7eybke.jpg" title alt="luly_brea-200x300.jpg" width="270" height="381" style="width: 270px; height: 381px;" referrerpolicy="no-referrer"><br></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-family: "times new roman"; font-size: 18px;">Fig. 3 </span><a href="https://news.feinberg.northwestern.edu/2022/09/02/molecular-mechanisms-regulating-prostate-cancer-hypoxia-identified/" target="_self">Lourdes Brea, a fourth-year student in the Driskill Graduate Program in Life Sciences</a> (</span><a href="https://www.feinberg.northwestern.edu/sites/dgp/current-students/index.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">DGP</span></a><span style="font-size: 18px; font-family: "times new roman";">), <a href="https://news.feinberg.northwestern.edu/2022/09/02/molecular-mechanisms-regulating-prostate-cancer-hypoxia-identified/" target="_self">was co-first author of the study.</a></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">据美国西北大学（</span><a href="http://www.northwestern.edu/" target="_blank" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: "times new roman";">Northwestern University</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）梅丽莎</span> </span><a href="https://news.feinberg.northwestern.edu/byline/melissa-rohman/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">·<span style="font-size: 18px; font-family: 宋体;">罗曼</span></span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">（</span> </span><a href="https://news.feinberg.northwestern.edu/byline/melissa-rohman/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Melissa Rohman</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）</span>2022<span style="font-size: 18px; font-family: 宋体;">年</span>9<span style="font-size: 18px; font-family: 宋体;">月</span>2<span style="font-size: 18px; font-family: 宋体;">日报道，美国西北大学和中国上海交通大学医学院的研究人员合作，确定了一种有助于调节去势抵抗性前列腺癌进展的分子机制（</span></span><a href="https://news.feinberg.northwestern.edu/2022/09/02/molecular-mechanisms-regulating-prostate-cancer-hypoxia-identified/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Molecular mechanisms regulating prostate cancer hypoxia identified</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）。相关研究结果于</span>2022<span style="font-size: 18px; font-family: 宋体;">年</span>8<span style="font-size: 18px; font-family: 宋体;">月</span>5<span style="font-size: 18px; font-family: 宋体;">日已经在《肿瘤基因》（</span> </span><a href="https://doi.org/10.1038/s41388-022-02423-6" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Oncogene</span></a><span style="font-size: 18px; font-family: "times new roman";">）杂志网站发表——</span><a href="https://www.nature.com/articles/s41388-022-02423-6#auth-Xiaohai-Wang" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Xiaohai Wang</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41388-022-02423-6#auth-Lourdes-Brea" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Lourdes Brea</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41388-022-02423-6#auth-Xiaodong-Lu" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Xiaodong Lu</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41388-022-02423-6#auth-Galina-Gritsina" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Galina Gritsina</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41388-022-02423-6#auth-Su_H_-Park" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Su H. Park</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41388-022-02423-6#auth-Wanqing-Xie" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Wanqing Xie</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41388-022-02423-6#auth-Jonathan_C_-Zhao" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Jonathan C. Zhao</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.nature.com/articles/s41388-022-02423-6#auth-Jindan-Yu" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Jindan Yu</span></a><span style="font-size: 18px; font-family: "times new roman";">. FOXA1 inhibits hypoxia programs through transcriptional repression of HIF1A, </span><a href="https://doi.org/10.1038/s41388-022-02423-6" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Oncogene</span></a><span style="font-size: 18px; font-family: "times new roman";"> (2022). </span><a href="https://dx.doi.org/10.1038/s41388-022-02423-6" target="_blank" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: "times new roman";">DOI: 10.1038/s41388-022-02423-6</span></a><span style="font-size: 18px; font-family: "times new roman";">. </span><a href="https://www.nature.com/articles/s41388-022-02423-6#article-info" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Published: 05 August 2022</span></a><span style="font-size: 18px; font-family: "times new roman";">. </span><a href="https://www.nature.com/articles/s41388-022-02423-6" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">https://www.nature.com/articles/s41388-022-02423-6</span></a></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">参与此项研究的有来自美国西北大学范伯格医学院医学系血液学</span>/<span style="font-size: 18px; font-family: 宋体;">肿瘤学部（</span>Division of Hematology/Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA<span style="font-size: 18px; font-family: 宋体;">）、西北大学范伯格医学院罗伯特·卢里综合癌症中心（</span>Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA<span style="font-size: 18px; font-family: 宋体;">）、西北大学范伯格医学院</span></span><a href="http://www.feinberg.northwestern.edu/sites/biochem/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">生物化学与分子遗传学</span></a><a href="https://www.medicine.northwestern.edu/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">系</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">（</span>Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA<span style="font-size: 18px; font-family: 宋体;">）的研究人员，以及来自中国上海交通大学医学院附属上海总医院（</span>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China<span style="font-size: 18px; font-family: 宋体;">）的研究人员。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">由西北大学范伯格医学院医学系</span><a href="https://www.medicine.northwestern.edu/divisions/hematology-oncology/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">血液学与肿瘤学</span></a><span style="font-size: 18px; font-family: "times new roman";">部和</span><a href="http://www.feinberg.northwestern.edu/sites/biochem/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">生物化学与分子遗传学</span></a><a href="https://www.medicine.northwestern.edu/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">系的医学</span></a><span style="font-size: 18px; font-family: "times new roman";">教授</span><a href="https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=18755" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">于金丹博士</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">（</span> </span><span style="text-decoration: underline; font-size: 18px; font-family: "times new roman";"><a href="https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=18755" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank">Jindan Yu, MD, PhD</a></span><span style="font-size: 18px; font-family: "times new roman"; text-decoration: none;">，Fig. 2</span><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）领导的研究人员发现，</span>FOXA1<span style="font-size: 18px; font-family: 宋体;">蛋白的下调调节前列腺癌肿瘤中的缺氧（</span><a href="https://news.feinberg.northwestern.edu/2022/09/02/molecular-mechanisms-regulating-prostate-cancer-hypoxia-identified/" target="_self">hypoxia</a><span style="font-size: 18px; font-family: 宋体;">）并促进肿瘤生长进展（</span></span><a href="https://medicalxpress.com/tags/tumor+progression/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">tumor progression</span></a><span style="font-size: 18px; font-family: "times new roman";">）。</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"> “FOXA1<span style="font-size: 18px; font-family: 宋体;">在抑制谱系可塑性方面的功能很重要，因为使患者致死的是去势抵抗性前列腺癌的转移和耐药性，</span>”<span style="font-size: 18px; font-family: 宋体;">于金丹说。</span> </span></p><p style="line-height: 2em;"><a href="https://www.feinberg.northwestern.edu/sites/dgp/current-students/index.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">德里斯基尔生命科学研究生课程</span> ( DGP</span></a><span style="font-size: 18px; font-family: "times new roman";"> )<span style="font-size: 18px; font-family: 宋体;">的四年级学生卢尔德斯·布瑞亚（</span>Lourdes Brea, Fig. 3<span style="font-size: 18px; font-family: 宋体;">）和上海交通大学医学院附属上海总医院的王晓海（</span></span><a href="https://www.nature.com/articles/s41388-022-02423-6#auth-Xiaohai-Wang" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Xiaohai Wang</span></a><span style="font-size: 18px; font-family: "times new roman";">音译）是该研究的共同第一作者。</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">前列腺癌是美国男性癌症相关死亡率的第二大原因。虽然放射和激素治疗（</span><a href="https://medicalxpress.com/tags/hormone+therapy/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">hormone therapy</span></a><span style="font-size: 18px; font-family: "times new roman";">）等治疗方案可有效治疗早期癌症，但许多患者会产生治疗抗性并进展为转移性去势抗性前列腺癌（</span><a href="https://medicalxpress.com/news/2022-09-molecular-mechanisms-prostate-cancer-hypoxia.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">castration-resistant prostate cancer</span></a><span style="font-size: 18px; font-family: "times new roman";">简称</span><a href="https://medicalxpress.com/news/2022-09-molecular-mechanisms-prostate-cancer-hypoxia.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">CRPC</span></a><span style="font-size: 18px; font-family: "times new roman";">）。</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">目前</span><a href="https://medicalxpress.com/news/2022-09-molecular-mechanisms-prostate-cancer-hypoxia.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">CRPC</span></a><span style="font-size: 18px; font-family: "times new roman";">的治疗选择对患者的益处有限，很少有研究调查</span><a href="https://medicalxpress.com/news/2022-09-molecular-mechanisms-prostate-cancer-hypoxia.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">CRPC</span></a><span style="font-size: 18px; font-family: "times new roman";">进展的缺氧分子机制，这对于开发有效的靶向治疗至关重要。</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">于金丹实验室等人最近的工作发现</span>FOXA1<span style="font-size: 18px; font-family: 宋体;">在前列腺癌转移中下调，提示</span>FOXA1<span style="font-size: 18px; font-family: 宋体;">可能在</span></span><a href="https://medicalxpress.com/news/2022-09-molecular-mechanisms-prostate-cancer-hypoxia.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">CRPC</span></a><span style="font-size: 18px; font-family: "times new roman";">中发挥抑癌作用。</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">在目前的研究中，于金丹和合作者旨在确定</span>FOXA1<span style="font-size: 18px; font-family: 宋体;">下调，是否控制前列腺肿瘤微环境中的缺氧编程并促进癌症进展。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">通过对前列腺癌细胞系进行体外分析，研究人员发现</span>FOXA1<span style="font-size: 18px; font-family: 宋体;">与</span>HIF1A<span style="font-size: 18px; font-family: 宋体;">蛋白结合，抑制其表达。反过来，</span>HIF1A<span style="font-size: 18px; font-family: 宋体;">有助于调节</span>FOXA1<span style="font-size: 18px; font-family: 宋体;">缺失诱导的缺氧基因表达。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">此外，通过</span> HIF1A<span style="font-size: 18px; font-family: 宋体;">，</span>FOXA1<span style="font-size: 18px; font-family: 宋体;">下调促进巨噬细胞浸润到肿瘤微环境（</span></span><a href="https://medicalxpress.com/tags/tumor+microenvironment/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">tumor microenvironment</span></a><span style="font-size: 18px; font-family: "times new roman";">）中，这有助于肿瘤变得免疫抑制并增加前列腺癌细胞的侵袭。</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"> “<span style="font-size: 18px; font-family: 宋体;">当巨噬细胞被招募到肿瘤中时，它们实际上可以拮抗</span>T<span style="font-size: 18px; font-family: 宋体;">细胞功能并削弱免疫反应（</span> </span><a href="https://medicalxpress.com/tags/immune+response/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">immune response</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">），这是很糟糕的，</span>”<span style="font-size: 18px; font-family: 宋体;">于金丹说。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">研究结果表明</span>FOXA1<span style="font-size: 18px; font-family: 宋体;">是调节</span></span><a href="https://medicalxpress.com/news/2022-09-molecular-mechanisms-prostate-cancer-hypoxia.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">CRPC</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">中缺氧肿瘤微环境和整体促进前列腺癌进展的关键参与者。现在，于金丹的团队正在研究</span>FOXA1<span style="font-size: 18px; font-family: 宋体;">在前列腺癌体内模型中调节免疫反应的作用。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">“我们分别不同意业内人士提出的以</span>FOXA1<span style="font-size: 18px; font-family: 宋体;">为治疗靶点的建议，因为它可能导致谱系可塑性、缺氧和</span>CRPC<span style="font-size: 18px; font-family: 宋体;">进展。我们认为应该针对</span>FOXA1<span style="font-size: 18px; font-family: 宋体;">缺失导致的上皮</span>-<span style="font-size: 18px; font-family: 宋体;">间质转化（</span></span><a href="https://medicalxpress.com/tags/epithelial-mesenchymal+transition/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">epithelial-mesenchymal transition</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）和缺氧程序来预防或治疗</span>CRPC<span style="font-size: 18px; font-family: 宋体;">，”于金丹说。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">这项工作得到了美国国立卫生研究院</span> (NIH) <span style="font-size: 18px; font-family: 宋体;">的资助（</span>NIH prostate SPORE P50CA180995<span style="font-size: 18px; font-family: 宋体;">；</span>NIH R50CA211271<span style="font-size: 18px; font-family: 宋体;">；</span>NIH/NCI training grant T32 CA009560<span style="font-size: 18px; font-family: 宋体;">）和前列腺癌基金会（</span>Prostate Cancer Foundation<span style="font-size: 18px; font-family: 宋体;">）的部分支持（</span>Prostate Cancer Foundation 2017CHAL2008<span style="font-size: 18px; font-family: 宋体;">）。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">上述介绍，仅供参考。欲了解更多信息，敬请注意浏览</span><a href="https://doi.org/10.1038/s41388-022-02423-6" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">原文</span></a><span style="font-size: 18px; font-family: "times new roman";">或者</span><a href="https://medicalxpress.com/news/2022-09-molecular-mechanisms-prostate-cancer-hypoxia.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">相关报道</span></a><span style="font-size: 18px; font-family: "times new roman";">。</span></p><p style="line-height: 2em;"><a href="https://medicalxpress.com/news/2021-04-uncovering-function-prostate-cancer-protein.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Uncovering the function of prostate cancer protein</span></a></p><p style="line-height: 2em;"><a href="https://doi.org/10.1038/s41388-022-02423-6" style="font-size: 18px; font-family: "arial black", "avant garde"; text-decoration: underline;" target="_blank"><span style="font-family: "arial black", "avant garde";">Abstract</span></a><br></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">Intratumoral hypoxia is associated with castration-resistant prostate cancer (CRPC), a lethal disease. FOXA1 is an epithelial transcription factor that is down-regulated in CRPC. We have previously reported that FOXA1 loss induces epithelial-mesenchymal transition (EMT) and cell motility through elevated TGFβ signaling. However, whether FOXA1 directly regulates hypoxia pathways of CRPC tumors has not been previously studied. Here we report that FOXA1 down-regulation induces hypoxia transcriptional programs, and FOXA1 level is negatively correlated with hypoxia markers in clinical prostate cancer (PCa) samples. Mechanistically, FOXA1 directly binds to an intragenic enhancer of HIF1A to inhibit its expression, and HIF1A, in turn, is critical in mediating FOXA1 loss-induced hypoxia gene expression. Further, we identify CCL2, a chemokine ligand that modulates tumor microenvironment and promotes cancer progression, as a crucial target of the FOXA1-HIF1A axis. We found that FOXA1 loss leads to immunosuppressive macrophage infiltration and increased cell invasion, dependent on HIF1A expression. Critically, therapeutic targeting of HIF1A-CCL2 using pharmacological inhibitors abolishes FOXA1 loss-induced macrophage infiltration and PCa cell invasion. In summary, our study reveals an essential role of FOXA1 in controlling the hypoxic tumor microenvironment and establishes the HIF1A-CCL2 axis as one mechanism of FOXA1 loss-induced CRPC progression.</span></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自诸平科学网博客。<br>链接地址：</label><a href="https://blog.sciencenet.cn/blog-212210-1354265.html" target="_blank" style="font-size:13px; color:#850f0f">https://blog.sciencenet.cn/blog-212210-1354265.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-212210-1354130.html" target="_black">量子猫的新皮毛:首次发现许多原子的纠缠</a><br>下一篇：<a href="http://blog.sciencenet.cn/blog-212210-1354418.html" target="_black">自种秋葵</a>                    <!--大赛结束-->
                                        
  
</div>
            